Getting the Deal Through: Pharmaceutical antitrust 2017

The following In House Advisor guidance note provides comprehensive and up to date legal information covering:

  • Getting the Deal Through: Pharmaceutical antitrust 2017
  • Jurisdictions covered
  • Questions
  • Pharmaceutical regulatory law
  • Competition legislation and regulation
  • Review of mergers
  • Anticompetitive agreements
  • Anticompetitive unilateral conduct

Click here to download the latest Pharmaceutical Antitrust 2017 report, published by Getting the Deal Through.

Jurisdictions covered

The following jurisdictions are covered in this report:

Brazil; China; European Union; Finland; France; Germany; India; Israel; Italy; Japan; Korea; Mexico; Poland; Portugal; Spain; Turkey; Ukraine; United Kingdom; United States.

Questions

The set of questions relating to the topic of Pharmaceutical antitrust and answered by the guide for each jurisdiction covered include:

  1. Pharmaceutical regulatory law

  2. Which legislation sets out the regulatory framework for the marketing, authorisation and pricing of pharmaceutical products, including generic drugs? Which bodies are entrusted with enforcing these rules?

  3. Is there specific legislation on the distribution of pharmaceutical products?

  4. Which aspects of this legislation are most directly relevant to the application of competition law to the pharmaceutical sector?

  5. Competition legislation and regulation

  6. Which legislation sets out competition law?

  7. Which authorities inv